Literature DB >> 21244612

Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.

Lars Budäus1, Jan Spethmann, Hendrik Isbarn, Jan Schmitges, Laura Beesch, Alexander Haese, Georg Salomon, Thorsten Schlomm, Margit Fisch, Hans Heinzer, Hartwig Huland, Markus Graefen, Thomas Steuber.   

Abstract

OBJECTIVE: • To investigate the stage migration patterns during the last decade in European men treated with radical prostatectomy (RP). PATIENTS AND METHODS: • Between 2000 and 2009, RP was performed in 8916 patients at a single European tertiary-care institution. • Age at diagnosis, clinical and pathological data were prospectively collected, and trends and proportions of preoperative and pathological findings were analysed over time.
RESULTS: • The median (mean) age of patients increased from 62 (62) to 63 (65) years between 2000 and 2009 (P < 0.001). • When patients were stratified based on their clinical findings according to the D'Amico risk groups for disease progression, the proportion of low-risk patients dropped from 66% in 2004 to 35% (P= 0.016) in the final year of the study period. • Similarly, histopathological evaluation of RP specimens showed a decrease of favourable disease (organ confinement and Gleason 3 + 3 grade) from 53 to 17% (P= 0.008). • This trend was accompanied by an increase in the number of patients with non-organ-confined prostate cancer (PCa) from 19% in 2003 to 33% in 2009 (P= 0.008). • The restriction of the analyses in the present study to a single tertiary-care centre could limit the generalizeability of the results.
CONCLUSIONS: • During the last decade, we observed an inverse stage migration trend in those European patients with PCa who were treated with RP. • The recorded increase in patients with non-organ-confined disease after RP could be related to changes in patient selection and the growing adoption of RP in multimodal treatment settings for locally advanced tumours as well as the availability of new treatment alternatives for low-risk disease.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244612     DOI: 10.1111/j.1464-410X.2010.09982.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  24 in total

Review 1.  Targeted prostate biopsy and MR-guided therapy for prostate cancer.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Abdom Radiol (NY)       Date:  2016-05

2.  [Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012].

Authors:  A Walther; M Kron; T Klorek; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 3.  The status of surgery in the management of high-risk prostate cancer.

Authors:  Christian Bach; Sailaja Pisipati; Datesh Daneshwar; Mark Wright; Edward Rowe; David Gillatt; Raj Persad; Anthony Koupparis
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

4.  Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.

Authors:  Nicola Fossati; Niccolò M Passoni; Marco Moschini; Giorgio Gandaglia; Alessandro Larcher; Massimo Freschi; Giorgio Guazzoni; Daniel D Sjoberg; Andrew J Vickers; Francesco Montorsi; Alberto Briganti
Journal:  BJU Int       Date:  2015-06-10       Impact factor: 5.588

Review 5.  Magnetic Resonance Image-Guided Focal Prostate Ablation.

Authors:  Sherif G Nour
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

6.  Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.

Authors:  Jean Baptiste Beauval; Guillaume Ploussard; Bastien Cabarrou; Mathieu Roumiguié; Adil Ouzzane; Jérome Gas; Annabelle Goujon; Gautier Marcq; Romain Mathieu; Sébastien Vincendeau; Xavier Cathelineau; Pierre Mongiat-Artus; Laurent Salomon; Michel Soulié; Arnaud Méjean; Alexandre de La Taille; Morgan Rouprêt; François Rozet
Journal:  World J Urol       Date:  2016-12-16       Impact factor: 4.226

Review 7.  [Radical prostatectomy in locally advanced prostate cancer].

Authors:  P Mandel; D Tilki; M Graefen
Journal:  Urologe A       Date:  2017-11       Impact factor: 0.639

8.  Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.

Authors:  Valentin H Meissner; Kathleen Herkommer; Birgitt Marten-Mittag; Jürgen E Gschwend; Andreas Dinkel
Journal:  J Cancer Surviv       Date:  2017-05-21       Impact factor: 4.442

9.  [Interdisciplinary and individualized therapy of prostate cancer : International prostate cancer symposium Bonn 2013 - challenges and targets].

Authors:  M Schwardt; J Debus; G Feick; B Hadaschik; M Hohenfellner; R Schüle; J-P Zacharias; S E Combs
Journal:  Urologe A       Date:  2015-11       Impact factor: 0.639

10.  An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.

Authors:  John B Eifler; Zhaoyang Feng; Brian M Lin; Michael T Partin; Elizabeth B Humphreys; Misop Han; Jonathan I Epstein; Patrick C Walsh; Bruce J Trock; Alan W Partin
Journal:  BJU Int       Date:  2012-07-26       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.